Protective role of TRPV2 in synaptic plasticity through the ERK1/ 2-CREB-BDNF pathway in chronic unpredictable mild stress rats

被引:4
|
作者
Zhou, Yitong [1 ]
Cong, Ting [2 ]
Chen, Jun [3 ]
Chu, Zhenchen [4 ]
Sun, Ye [1 ]
Zhao, Danmei [1 ]
Chen, Xue [1 ]
Li, Liya [1 ]
Liu, Yingxin [5 ]
Cheng, Jiani [1 ]
Li, Qiwei [1 ]
Yin, Shengming [5 ]
Xiao, Zhaoyang [1 ]
机构
[1] Dalian Med Univ, Affliated Hosp 2, Dept Anesthesiol, 467 Zhongshan Rd, Dalian 116027, Liaoning, Peoples R China
[2] Qingdao Univ, Affiliated Hosp, Dept Anesthesiol, Qingdao 266000, Shandong, Peoples R China
[3] Dalian Med Univ, Lab Anim Ctr, Dalian 116044, Liaoning, Peoples R China
[4] Qingdao Municipal Hosp, Dept Orthoped, Qingdao 266011, Shandong, Peoples R China
[5] Dalian Med Univ, Basic Med Coll, Dept Physiol, 9,West Sect,Lvshun South Rd, Dalian 116044, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
Depression; CUMS; TRPV2; Synaptic plasticity; ERK1/2-CREB-BDNF signaling pathway; L-KYNURENINE; BDNF; CREB; ACTIVATION; OUTGROWTH; NEURONS; SYSTEM;
D O I
10.1016/j.bbrc.2024.150128
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose: Chronic stress is a significant risk factor for mood disorders such as depression, where synaptic plasticity plays a central role in pathogenesis. Transient Receptor Potential Vanilloid Type-2 (TRPV2) Ion Channels are implicated in hypothalamic-pituitary-adrenal axis disorders. Previous proteomic analysis indicated a reduction in TRPV2 levels in the chronic unpredictable mild stress (CUMS) rat model, yet its role in synaptic plasticity during depression remains to be elucidated. This study aims to investigate TRPV2's role in depression and its underlying mechanisms. Methods: In vivo and in vitro experiments were conducted using the TRPV2-specific agonist probenecid and ERK1/2 inhibitors SCH772984. In vivo, rats underwent six weeks of CUMS before probenecid administration. Depressive-like behaviors were assessed through behavioral tests. ELISA kits measured 5-HT, DA, NE levels in rat hippocampal tissues. Hippocampal morphology was examined via Nissl staining. In vitro, rat hippocampal neuron cell lines were treated with ERK1/2 inhibitors SCH772984 and probenecid. Western blot, immunofluorescence, immunohistochemical staining, and RT-qPCR assessed TRPV2 expression, neurogenesis-related proteins, synaptic markers, and ERK1/2-CREB-BDNF signaling proteins. Results: Decreased hippocampal TRPV2 levels were observed in CUMS rats. Probenecid treatment mitigated depressive-like behavior and enhanced hippocampal 5-HT, NE, and DA levels in CUMS rats. TRPV2 activation countered CUMS-induced synaptic plasticity inhibition. Probenecid activated the ERK1/2-CREB-BDNF pathway, suggesting TRPV2's involvement in this pathway via ERK1/2. Conclusion: These findings indicate that TRPV2 activation offers protective effects against depressive-like behaviors and enhances hippocampal synaptic plasticity in CUMS rats via the ERK1/2-CREB-BDNF pathway. TRPV2 emerges as a potential therapeutic target for depression.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Localization of AMP kinase is regulated by stress, cell density, and signaling through the MEK → ERK1/2 pathway
    Kodiha, Mohamed
    Rassi, James G.
    Brown, Claire M.
    Stochaj, Ursula
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 293 (05): : C1427 - C1436
  • [32] Tanshinone IIA ameliorates chronic unpredictable mild stress-induced depression-like behavior and cognitive impairment in rats through the BDNF/TrkB/GAT1 signaling pathway
    Liu, Shang-Zhi
    Yang, Jie
    Chen, Lin-Lin
    Wang, Ping
    Lin, Li
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 938
  • [33] Quercetin alleviates chronic unpredictable mild stress-induced depressive-like behaviors by promoting adult hippocampal neurogenesis via FoxG1/CREB/ BDNF signaling pathway
    Ma, Zhong-Xuan
    Zhang, Ru-Yi
    Rui, Wen-Juan
    Wang, Zhi-Qing
    Feng, Xia
    BEHAVIOURAL BRAIN RESEARCH, 2021, 406
  • [34] Resveratrol prevents cognitive deficits induced by chronic unpredictable mild stress: Sirt1/miR-134 signalling pathway regulates CREB/BDNF expression in hippocampus in vivo and in vitro
    Shen, Jun
    Xu, Linling
    Qu, Chujie
    Sun, Huimin
    Zhang, Junjian
    BEHAVIOURAL BRAIN RESEARCH, 2018, 349 : 1 - 7
  • [35] Artemisinin attenuated ischemic stroke induced cell apoptosis through activation of ERK1/2/CREB/BCL-2 signaling pathway in vitro and in vivo
    Peng, Tangming
    Li, Shuai
    Liu, Linlin
    Yang, Chao
    Farhan, Mohd
    Chen, Ligang
    Su, Qiaozhu
    Zheng, Wenhua
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (11): : 4578 - 4594
  • [36] The beneficial effects of vortioxetine on BDNF, CREB, S100B, β amyloid, and glutamate NR2b receptors in chronic unpredictable mild stress model of depression
    Unal, Gulin Ozdamar
    Erkilinc, Gamze
    Ozturk, Kuyas Hekimler
    Doguc, Duygu Kumbul
    Ozmen, Ozlem
    PSYCHOPHARMACOLOGY, 2023, 240 (12) : 2499 - 2513
  • [37] The beneficial effects of vortioxetine on BDNF, CREB, S100B, β amyloid, and glutamate NR2b receptors in chronic unpredictable mild stress model of depression
    Gülin Özdamar Ünal
    Gamze Erkılınç
    Kuyaş Hekimler Öztürk
    Duygu Kumbul Doguç
    Özlem Özmen
    Psychopharmacology, 2023, 240 : 2499 - 2513
  • [38] Curcumin Relieves Chronic Unpredictable Mild Stress-Induced Depression-Like Behavior through the PGC-1α/FNDC5/BDNF Pathway
    Wu, Yanqin
    Sun, Fusheng
    Guo, Yujin
    Zhang, Yumao
    Li, Li
    Dang, Ruili
    Jiang, Pei
    BEHAVIOURAL NEUROLOGY, 2021, 2021
  • [39] The Protective Effect of Docosahexaenoic Acid on PC12 Cells in Oxidative Stress Induced by H2O2 through the TrkB-Erk1/2-CREB Pathway
    Bie, Nana
    Feng, Xiaojuan
    Li, Chenjing
    Meng, Meng
    Wang, Chunling
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (18): : 3433 - 3444
  • [40] Influence of miR-34a on myocardial apoptosis in rats with acute myocardial infarction through the ERK1/2 pathway
    Bian, W-S.
    Tian, F-H.
    Jiang, L-H.
    Sun, Y-F.
    Wu, S-X.
    Gao, B-F.
    Kang, Z-X.
    Zhuo, Z.
    Zhang, X-Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (07) : 3034 - 3041